KRAS and cancer: Another indirect anti-RAS strategy involves targeting the DNA damage response (DDR) that allows cancer cells to counteract the lethal consequences of oncogenic KRAS-induced replicative stress and genomic instability (Luo et al., 2009; Grabocka et al., 2015; Primo and Teixeira, 2019).